Archives: Resources

Supporting database freezes more than two years sooner than planned for two HIV prevention trials network PrEP studies.

Remote monitoring strategies deliver quality, continuity and minimize trial disruptions at HIV/AIDS network sites during height of pandemic.

Navigate the evolving landscape and leverage trends to overcome challenges, accelerate timelines and enhance efficiency.

Unlock the secrets to successful regulatory engagements for small biotech companies and equip your team with essential knowledge to navigate regulatory complexities and accelerate development timelines.

A new study by the Tufts Center for the Study of Drug Development reveals significant value in a fully integrated development model.

This white paper examines the key regulatory and ethical considerations for creating inclusive and representative clinical trial populations to improve the accuracy and relevance of research outcomes.

Learn more about the use of AI in drug development and clinical research processes.

Explore this report to understand evolving patient experience trends, recruitment challenges, and patient-first strategies for enhancing clinical trial success and confidence.

Our industry-leading experience includes clinical trials for the treatment of HIV, chronic hepatitis B and C, hepatitis D, RSV, influenza as well as various bacterial, fungal, and parasitic diseases.